Encompass Health’s (EHC) Strong-Buy Rating Reiterated at Raymond James

Encompass Health (NYSE:EHC)‘s stock had its “strong-buy” rating restated by stock analysts at Raymond James in a note issued to investors on Friday, Benzinga reports. They currently have a $95.00 price target on the stock, up from their prior price target of $85.00. Raymond James’ price objective would indicate a potential upside of 14.87% from the company’s previous close.

Several other research firms have also recently issued reports on EHC. Royal Bank of Canada reissued an “outperform” rating and issued a $83.00 price objective on shares of Encompass Health in a research report on Friday, February 9th. Mizuho upped their price target on shares of Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Thursday. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research note on Wednesday, February 7th. Barclays increased their price objective on shares of Encompass Health from $101.00 to $108.00 and gave the stock an “overweight” rating in a research note on Thursday. Finally, Stephens restated an “overweight” rating and set a $85.00 price target on shares of Encompass Health in a research report on Tuesday, January 16th. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $86.56.

Encompass Health Stock Performance

NYSE:EHC traded down $0.03 during trading hours on Friday, reaching $82.70. The company had a trading volume of 335,959 shares, compared to its average volume of 668,036. The firm’s 50 day moving average price is $78.07 and its 200-day moving average price is $70.76. The firm has a market cap of $8.28 billion, a price-to-earnings ratio of 22.35, a PEG ratio of 1.53 and a beta of 0.94. Encompass Health has a 52 week low of $57.55 and a 52 week high of $85.84. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.19.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, topping the consensus estimate of $0.93 by $0.19. The business had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.27 billion. Encompass Health had a net margin of 7.60% and a return on equity of 18.48%. The business’s quarterly revenue was up 13.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.88 EPS. On average, analysts forecast that Encompass Health will post 3.96 EPS for the current year.

Institutional Investors Weigh In On Encompass Health

Several large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its stake in Encompass Health by 4.7% during the 4th quarter. Vanguard Group Inc. now owns 9,997,034 shares of the company’s stock worth $667,002,000 after buying an additional 450,081 shares during the period. Wellington Management Group LLP increased its position in shares of Encompass Health by 5.8% in the 4th quarter. Wellington Management Group LLP now owns 8,215,770 shares of the company’s stock valued at $548,156,000 after purchasing an additional 449,230 shares during the last quarter. William Blair Investment Management LLC increased its position in shares of Encompass Health by 6.4% in the 3rd quarter. William Blair Investment Management LLC now owns 5,676,379 shares of the company’s stock valued at $381,226,000 after purchasing an additional 342,512 shares during the last quarter. Invesco Ltd. increased its position in shares of Encompass Health by 22.3% in the 3rd quarter. Invesco Ltd. now owns 3,974,306 shares of the company’s stock valued at $266,914,000 after purchasing an additional 724,544 shares during the last quarter. Finally, TD Asset Management Inc increased its position in shares of Encompass Health by 239.6% in the 4th quarter. TD Asset Management Inc now owns 1,969,186 shares of the company’s stock valued at $131,384,000 after purchasing an additional 1,389,275 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.